The same physician can be a Tier 1 target for one model and a hard pass for another.
I ran two sourcing engagements in parallel recently.
Same general specialty. Different buyer models.
When I started building the signal layer for each, the target universe started to split in a way that would not have shown up in a generic screen.
Physicians who looked attractive for one buyer would have been screened out entirely for the other.
The data was not the issue.
The underlying buyer model was different.
The signal stack you build is downstream of your model, not your market.
From what I’ve seen, a lot of healthcare M&A sourcing still starts with what I’d call the classic platform acquisition profile: a physician-owner who is nearing a transition, but still engaged enough to carry the practice through the first few years post-close.
The signals usually cluster around the same pattern:
Physician in their mid-to-late 50s
No obvious succession plan
Partner departures or provider movement
Lease renewal pressure
Reimbursement headwinds
Competitor platform activity nearby
Those are exit-proximity signals.
They help identify when a physician may be approaching the end of independent ownership, either by choice or by pressure.
But the better traditional acquirers are usually not looking for someone who is fully checked out. That is where the screen can get too blunt.
In high-touch specialties, physician reputation is sticky.
Patient and referral relationships do not transfer cleanly to a new operator.
A strong acquisition target is often somewhere in the middle: motivated enough to consider a transaction, but still engaged enough to help bridge the first 12 to 36 months post-close while the platform builds its own referral infrastructure.
That is the profile the signal stack is trying to find.
Momentum slowing, but not gone.
Now flip the model.
In JV-style structures I’ve seen, the economics only work if the physician keeps building after close.
The physician stays in the business, keeps operating, and often keeps meaningful upside.
That changes what you are screening for.
A physician approaching 60 with a succession gap may look attractive in a cash-out model.
For a JV buyer, that same profile can raise the wrong questions.
Is this physician still trying to build?
Do they want a partner, or do they want an exit?
Are they looking for growth capital, or are they trying to de-risk the next chapter?
The physician who fits a JV model is usually mid-career, growth-oriented, platform-naive, and not looking for maximum liquidity at close.
They want capital, infrastructure, and a partner who will not take the wheel.
The upside is the draw, not the check.
Same market.
Same specialty.
Different thesis.
Different target.
